ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) announced that CEO Chris Xu will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. His presentation is scheduled for September 14, 2022, at 12:00pm Eastern Time. The event will include in-person and virtual meetings for institutional investors. Attendees can request meetings through the conference website. A live webcast of the presentation will be accessible on the company’s website, with an archived replay available for 90 days.

RANCHO CORDOVA, Calif., Sept. 7, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview at the H.C. Wainwright 24^th Annual Global Investment Conference, taking place September 12-14, 2022.  Details of Dr. Xu's in-person presentation are as follows:

Date: Wednesday, September 14, 2022
Time: 12:00pm Eastern Time

Dr. Xu will also host in-person and virtual one-on-one meetings during the event. Institutional investors who are registered for the conference can log into www.hcwevents.com to request a meeting with the company

A live webcast of the presentation will be available on the ThermoGenesis website at: https://ThermoGenesis.com/investors/news-and-events/events-webcasts.

An archived replay will be available for a period of 90 days after the conference.

About ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact: 
Wendy Samford
916-858-5191
ir@thermogenesis.com

Investor Contact: 
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

 

View original content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-present-at-the-hc-wainwright-24th-annual-global-investment-conference-301619020.html

SOURCE ThermoGenesis Holdings, Inc.

FAQ

When will ThermoGenesis Holdings present at the H.C. Wainwright conference?

ThermoGenesis Holdings will present on September 14, 2022, at 12:00pm Eastern Time.

Who is presenting for ThermoGenesis at the investment conference?

CEO Chris Xu will present for ThermoGenesis at the H.C. Wainwright conference.

Is there a live webcast for the ThermoGenesis presentation?

Yes, a live webcast will be available on ThermoGenesis's website.

How long will the ThermoGenesis presentation replay be available?

The archived replay of the presentation will be available for 90 days after the conference.

Where can investors request meetings during the H.C. Wainwright conference?

Investors can request meetings through the conference website at www.hcwevents.com.